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Identity 
Other names: KIAA0407; MGC149167; 
OTTHUMP00000164806; PLEXIN-B1; PLXN5; SEP 
HGNC (Hugo): PLXNB1 
Location: 3p21.31 
Local order: The Plexin B1 gene is located between 
FBXW12 and CCDC51 genes. 
 
Note 
Size: 26,200 bases. 
Orientation: minus strand. 
DNA/RNA 
Description 
Functioning gene. 21.00 kb; 37 Exons. 
Transcription 
7097.00 bp; Number of transcripts: 1; Type: 
Messenger. 
Two alternatively truncated spliced variant, coding 






2135 Amino acids (AA). Plexins are receptors for axon 
molecular guidance molecules semaphorins. Plexin 
signalling is important in pathfinding and patterning of 
both neurons and developing blood vessels. Plexin-B1 
is a surface cell receptor. When it binds to its ligand 
SEMA4D it activates several pathways by binding of 
cytoplasmic ligands, like RHOA activation and 
subsequent changes of the actin cytoskeleton, axon 
guidance, invasive growth and cell migration. 
It monomers and heterodimers with PLXNB2 after 
proteolytic processing. Binds RAC1 that has been 
activated by GTP binding. 
It binds PLXNA1 and by similarity ARHGEF11, 
ARHGEF12, ERBB2, MET, MST1R, RND1, NRP1 
and NRP2. 
This family features the C-terminal regions of various 
plexins. The cytoplasmic region, which has been called 
a SEX domain in some members of this family is 
involved in downstream signalling pathways, by 
interaction with proteins such as Rac1, RhoD, Rnd1 
and other plexins. 
Three copies of a cysteine rich repeat are found in 
Plexin. The function of the repeat is unknown. 
Expression 
It is highly expressed in fetal kidney, digestive system 
(from esophagus to colon), thyroid, prostate and 
trachea and at slightly lower levels in fetal brain, lung, 
female reproductive system (breast, uterus and ovary) 
and liver. 
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Plexin B1 policlonal antibody in foetal human central nervous system. Positive staining in developing neurons. 
 
Localisation 
Three isoforms have been identified: The isoform 1 is 
located in cell membrane and the isoforms 2 and 3 are 
secreted proteins. 
Function 
Plexin B1 has several molecular functions, like a 
receptor activity, transmembrane receptor activity, 
protein binding, semaphorin receptor and semaphorin 
receptor binding. It is implicated in the next biological 
processes: Signal transduction, intracellular signalling 
cascade, multicellular organismal development, cell 
migration and posi-tive regulation of axonogenesis. 
Homology 
It belongs to the plexin family and it contains 3 
IPT/TIG domains and one Sema domain. 
Mutations 
Somatic 




mutations in the cytoplasmic domain of the PLXNB1  
gene in prostate cancer tissue. Mutations were found in  
8 (89%) of 9 prostate cancer bone metastases, in 7 
(41%) of 17 lymph node meta-stases, and in 41 (46%) 
of 89 primary cancers. Forty percent of prostate cancers 
contained the same mutation, and the majority of the 
primary tumors showed overexpression of the plexin- 
B1 protein. In vitro functional expression studies of the  
3 most common mutations showed that the mutant 
proteins resulted in increased cell motility, inva-sion, 
adhesion, and lamellipodia extension compared to 
wildtype. The mutations acted by hindering RAC1 and 




Loss of protein Plexin B1 expression is associated with 
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Renal cell carcinoma 
Note 
By reverse transcription-polymerase chain reaction  
 
plexin B1 is expressed in nonneoplastic renal tissue,  
and it is severely downregulated in clear cell renal 
carcinomas. By immunohistochemistry on tissue 
microarrays it was shown that plexin B1 protein is 
absent in more than 80% of renal cell carcinomas. 
Otherwise, all kinds of renal tubules showed strong 
membrane reactivity. 
When plexin B1 expression is induced with an 
expression vector in the renal adenocarcinoma cell line 




13 somatic missense mutations in the cytoplasmic 
domain of the Plexin-B1 gene have been reported. 
Mutations were found in cancer bone metastases, 
lymph node metastases, and in primary cancers.  
Forty percent of prostate cancers contained the same 
mutation. Overexpression of the Plexin-B1 protein was 
found in the majority of primary tumors. The mutations 
hinder Rac and R-Ras binding and R-RasGAP activity, 
resulting in an increase in cell motility, invasion, 
adhesion, and lamellipodia. 
 
 
Plexin B1 in normal kidney tissue. 
Tubular cortical and medular cells reactive 
The same immunostaining after blocking peptide incubation. 
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Plexin B1 loss of expression in three cases of renal cell carcinoma (clear cell upper right and left), and papillary (bottom right). One case 




Using semi-quantitative reverse transcription 
polymerase chain reaction (RT-PCR) analysis, plexin 
B1 (PLXNB1) was confirmed to be consis-tently 
expressed at lower levels in osteoarthritis. 
Disease 
Degenerative bone disease. 
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